Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARL4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAXDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGSF22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5DC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM193B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506675 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SEPT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASCL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929583 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM182 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBAP2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00887 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on